The £7.5 million (~$10 million) Longitude Prize on ALS incentivises the use of AI-based approaches to transform drug discovery for amyotrophic lateral sclerosis (ALS), the most common form of motor neurone disease (MND).
Longitude Prize on ALS application window is now live!
We are looking for fresh thinking and the brightest minds to join us in bringing AI to the fight against ALS.
Entries are open from Wednesday 25th June 2025 – Wednesday 3rd December 2025.
Register to be a competing team
Interested in learning more about the Prize? Watch this to get an overview of how it works.
ECHAlliance The Global Health Connector: Connecting the dots between people, knowledge and innovation
info@echalliance.com
Connected Health Alliance CIC, NISP Innovation Centre, Queen’s Road, Queen’s Island, Belfast, United Kingdom, BT3 9DT
ECHAlliance CLG, 20 Harcourt Street Dublin, D02H364, Ireland
